Introduction to Liquid Biopsy in Ovarian Cancer Ovarian cancer remains one of the most lethal gynecological malignancies worldwide, primarily due to its asymptomatic nature in
Introduction The landscape of gynecologic oncology has historically been constrained by the limitations of conventional chemotherapy, particularly for patients who develop platinum-resistant disease. Says Dr. Scott
Introduction The landscape of gynecological oncology is undergoing a profound paradigm shift as traditional diagnostic methods, often reliant on invasive procedures and subjective histopathological assessments,
Introduction The management of ovarian cancer has long been characterized by a reliance on systemic platinum-based chemotherapy, which, while initially effective, frequently leads to the
Introduction The landscape of uterine oncology has undergone a profound transformation in recent years, shifting from a traditional histomorphological classification to a sophisticated molecular-driven framework.
Introduction Ovarian cancer remains one of the most challenging gynecologic malignancies to treat effectively due to its high propensity for recurrence and the frequent development
Introduction to the Immunotherapy Paradigm Shift The landscape of gynecologic oncology has undergone a transformative shift in recent years, particularly regarding the management of uterine
Introduction to Precision Oncology The management of ovarian cancer has historically relied on a “one-size-fits-all” approach, typically involving cytoreductive surgery followed by platinum-based chemotherapy. While
Introduction Ovarian carcinoma remains one of the most lethal gynecological malignancies, primarily due to its propensity for late-stage diagnosis. The absence of specific symptoms during
Introduction: The Dawn of Precision Gynecology The landscape of uterine medicine is undergoing a profound transformation as traditional, one-size-fits-all diagnostic models give way to highly